{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T03:20:26Z","timestamp":1780975226356,"version":"3.54.1"},"reference-count":69,"publisher":"Bentham Science Publishers Ltd.","issue":"6","funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"publisher","award":["2019YFA090402"],"award-info":[{"award-number":["2019YFA090402"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Major Health Risk Management and TCM Prevention and Control Policy Research Center","award":["JKFXFK-013"],"award-info":[{"award-number":["JKFXFK-013"]}]},{"name":"Science and Technology Demonstration Project for Social Development of Jiangyin Science and Technology Bureau","award":["JY0603-A011014-220011-PB"],"award-info":[{"award-number":["JY0603-A011014-220011-PB"]}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAD"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>The novel coronavirus disease 2019 (COVID-19) caused by severe acute\nrespiratory syndrome coronavirus 2 (SARS-CoV-2) has led to a worldwide public health crisis. At\npresent, the development of effective drugs and\/or related therapeutics is still the most urgent and\nimportant task for combating the virus. The viral entry and associated infectivity mainly rely on\nits envelope spike protein to recognize and bind to the host cell receptor angiotensin-converting\nenzyme 2 (ACE2) through a conformational switch of the spike receptor binding domain (RBD)\nfrom inactive to active state. Thus, it is of great significance to design an allosteric inhibitor targeting\nspike to lock it in the inactive and ACE2-inaccessible state.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>This study aims to discover the potential broad-spectrum allosteric inhibitors capable\nof binding and stabilizing the diverse spike variants, including the wild type, Delta, and Omicron,\nin the inactive RBD down state.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>In this work, we first detected a potential allosteric pocket within the SARS-CoV-2\nspike protein. Then, we performed large-scale structure-based virtual screening by targeting the\nputative allosteric pocket to identify allosteric inhibitors that could stabilize the spike inactive\nstate. Molecular dynamics simulations were further carried out to evaluate the effects of compound\nbinding on the stability of spike RBD.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Result:<\/jats:title>\n<jats:p>Finally, we identified three potential allosteric inhibitors, CPD3, CPD5, and CPD6,\nagainst diverse SARS-CoV-2 variants, including Wild-type, Delta, and Omicron variants. Our\nsimulation results showed that the three compounds could stably bind the predicted allosteric site\nand effectively stabilize the spike in the inactive state.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The three compounds provide novel chemical structures for rational drug design targeting\nspike protein, which is expected to greatly assist in the development of new drugs against\nSARS-CoV-2.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573409919666230726142418","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T11:11:37Z","timestamp":1690369897000},"page":"784-797","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Discovery of a Potential Allosteric Site in the SARS-CoV-2 Spike Protein\nand Targeting Allosteric Inhibitor to Stabilize the RBD Down State using a\nComputational Approach"],"prefix":"10.2174","volume":"20","author":[{"given":"Tong","family":"Li","sequence":"first","affiliation":[{"name":"School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 210009, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Yan","sequence":"additional","affiliation":[{"name":"The Affiliated\nJiangyin Hospital of Nanjing University of Chinese Medicine, Jiangyin 214400, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 210009, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 210009, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Basic Medicine and\nClinical Pharmacy, China Pharmaceutical University, Nanjing, 210009, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibing","family":"Hua","sequence":"additional","affiliation":[{"name":"The Affiliated\nJiangyin Hospital of Nanjing University of Chinese Medicine, Jiangyin 214400, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"Zhu N.","year":"2020","unstructured":"Zhu N.; Zhang D.; Wang W.; Li X.; Yang B.; Song J.; Zhao X.; Huang B.; Shi W.; Lu R.; Niu P.; Zhan F.; Ma X.; Wang D.; Xu W.; Wu G.; Gao G.F.; Tan W.; A novel coronavirus from patients with pneumonia in china, 2019. N Engl J Med  2020,382(8),727-733","journal-title":"N Engl J Med"},{"key":"ref=2","year":"2022","unstructured":"WHO Coronavirus Disease (COVID-19) Dashboard. World Health Organization Available from:  https:\/\/covid19.who.int\/2022"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/17512433.2021.1902303","volume":"14","author":"Rahman S.","year":"2021","unstructured":"Rahman S.; Montero M.T.V.; Rowe K.; Kirton R.; Kunik F.; Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: A review of current evidence. Expert Rev Clin Pharmacol  2021,14(5),601-621","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref=4","year":"2022","unstructured":"Coronavirus (COVID-19) | Drugs. Food and Drug Administration Available from:  https:\/\/www.fda.gov\/drugs\/emergency-preparedness-drugs\/coronavirus-covid-19-drugs2022"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1016\/j.jinf.2020.12.024","volume":"82","author":"Tang J.W.","year":"2021","unstructured":"Tang J.W.; Tambyah P.A.; Hui D.S.C.; Emergence of a new SARS-CoV-2 variant in the UK. J Infect  2021,82(4),e27-e28","journal-title":"J Infect"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.cmi.2021.05.022","volume":"27","author":"Boehm E.","year":"2021","unstructured":"Boehm E.; Kronig I.; Neher R.A.; Eckerle I.; Vetter P.; Kaiser L.; Novel SARS-CoV-2 variants: The pandemics within the pandemic. Clin Microbiol Infect  2021,27(8),1109-1117","journal-title":"Clin Microbiol Infect"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1016\/j.jinf.2021.01.007","volume":"82","author":"Tang J.W.","year":"2021","unstructured":"Tang J.W.; Toovey O.T.R.; Harvey K.N.; Hui D.S.C.; Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK. J Infect  2021,82(4),e8-e10","journal-title":"J Infect"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJMoa2108891","volume":"385","author":"Lopez Bernal J.","year":"2021","unstructured":"Lopez Bernal J.; Andrews N.; Gower C.; Gallagher E.; Simmons R.; Thelwall S.; Stowe J.; Tessier E.; Groves N.; Dabrera G.; Myers R.; Campbell C.N.J.; Amirthalingam G.; Edmunds M.; Zambon M.; Brown K.E.; Hopkins S.; Chand M.; Ramsay M.; Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta). Variant N Engl J Med  2021,385(7),585-594","journal-title":"Variant N Engl J Med"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41577-021-00662-4","volume":"22","author":"Lipsitch M.","year":"2022","unstructured":"Lipsitch M.; Krammer F.; Regev-Yochay G.; Lustig Y.; Balicer R.D.; SARS-CoV-2 breakthrough infections in vaccinated individuals: Measurement, causes and impact. Nat Rev Immunol  2022,22(1),57-65","journal-title":"Nat Rev Immunol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"100721","DOI":"10.1016\/j.drup.2020.100721","volume":"53","author":"Artese A.","year":"2020","unstructured":"Artese A.; Svicher V.; Costa G.; Salpini R.; Di Maio V.C.; Alkhatib M.; Ambrosio F.A.; Santoro M.M.; Assaraf Y.G.; Alcaro S.; Ceccherini-Silberstein F.; Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses. Drug Resist Updat  2020,53,100721","journal-title":"Drug Resist Updat"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","volume":"583","author":"Gordon D.E.","year":"2020","unstructured":"Gordon D.E.; Jang G.M.; Bouhaddou M.; Xu J.; Obernier K.; White K.M.; O\u2019Meara M.J.; Rezelj V.V.; Guo J.Z.; Swaney D.L.; Tummino T.A.; H\u00fcttenhain R.; Kaake R.M.; Richards A.L.; Tutuncuoglu B.; Foussard H.; Batra J.; Haas K.; Modak M.; Kim M.; Haas P.; Polacco B.J.; Braberg H.; Fabius J.M.; Eckhardt M.; Soucheray M.; Bennett M.J.; Cakir M.; McGregor M.J.; Li Q.; Meyer B.; Roesch F.; Vallet T.; Mac Kain A.; Miorin L.; Moreno E.; Naing Z.Z.C.; Zhou Y.; Peng S.; Shi Y.; Zhang Z.; Shen W.; Kirby I.T.; Melnyk J.E.; Chorba J.S.; Lou K.; Dai S.A.; Barrio-Hernandez I.; Memon D.; Hernandez-Armenta C.; Lyu J.; Mathy C.J.P.; Perica T.; Pilla K.B.; Ganesan S.J.; Saltzberg D.J.; Rakesh R.; Liu X.; Rosenthal S.B.; Calviello L.; Venkataramanan S.; Liboy-Lugo J.; Lin Y.; Huang X.P.; Liu Y.; Wankowicz S.A.; Bohn M.; Safari M.; Ugur F.S.; Koh C.; Savar N.S.; Tran Q.D.; Shengjuler D.; Fletcher S.J.; O\u2019Neal M.C.; Cai Y.; Chang J.C.J.; Broadhurst D.J.; Klippsten S.; Sharp P.P.; Wenzell N.A.; Kuzuoglu-Ozturk D.; Wang H.Y.; Trenker R.; Young J.M.; Cavero D.A.; Hiatt J.; Roth T.L.; Rathore U.; Subramanian A.; Noack J.; Hubert M.; Stroud R.M.; Frankel A.D.; Rosenberg O.S.; Verba K.A.; Agard D.A.; Ott M.; Emerman M.; Jura N.; von Zastrow M.; Verdin E.; Ashworth A.; Schwartz O.; d\u2019Enfert C.; Mukherjee S.; Jacobson M.; Malik H.S.; Fujimori D.G.; Ideker T.; Craik C.S.; Floor S.N.; Fraser J.S.; Gross J.D.; Sali A.; Roth B.L.; Ruggero D.; Taunton J.; Kortemme T.; Beltrao P.; Vignuzzi M.; Garc\u00eda-Sastre A.; Shokat K.M.; Shoichet B.K.; Krogan N.J.; A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature  2020,583(7816),459-468","journal-title":"Nature"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/1061186X.2020.1853736","volume":"29","author":"Jamalipour Soufi G.","year":"2021","unstructured":"Jamalipour Soufi G.; Iravani S.; Potential inhibitors of SARS-CoV-2: Recent advances. J Drug Target  2021,29(4),349-364","journal-title":"J Drug Target"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.apsb.2021.02.011","volume":"11","author":"Li Q.","year":"2021","unstructured":"Li Q.; Yi D.; Lei X.; Zhao J.; Zhang Y.; Cui X.; Xiao X.; Jiao T.; Dong X.; Zhao X.; Zeng H.; Liang C.; Ren L.; Guo F.; Li X.; Wang J.; Cen S.; Corilagin inhibits SARS-CoV-2 replication by targeting viral RNA-dependent RNA polymerase. Acta Pharm Sin B  2021,11(6),1555-1567","journal-title":"Acta Pharm Sin B"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1126\/science.abi5224","volume":"373","author":"Maio N.","year":"2021","unstructured":"Maio N.; Lafont B.A.P.; Sil D.; Li Y.; Bollinger J.M.; Krebs C.; Pierson T.C.; Linehan W.M.; Rouault T.A.; Fe-S cofactors in the SARS-CoV-2 RNA-dependent RNA polymerase are potential antiviral targets. Science  2021,373(6551),236-241","journal-title":"Science"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1002\/med.21783","volume":"41","author":"Xiong M.","year":"2021","unstructured":"Xiong M.; Su H.; Zhao W.; Xie H.; Shao Q.; Xu Y.; What coronavirus 3C\u2010like protease tells us: From structure, substrate selectivity, to inhibitor design. Med Res Rev  2021,41(4),1965-1998","journal-title":"Med Res Rev"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1126\/science.abg5827","volume":"373","author":"Drayman N.","year":"2021","unstructured":"Drayman N.; DeMarco J.K.; Jones K.A.; Azizi S.A.; Froggatt H.M.; Tan K.; Maltseva N.I.; Chen S.; Nicolaescu V.; Dvorkin S.; Furlong K.; Kathayat R.S.; Firpo M.R.; Mastrodomenico V.; Bruce E.A.; Schmidt M.M.; Jedrzejczak R.; Mu\u00f1oz-Al\u00eda M.\u00c1.; Schuster B.; Nair V.; Han K.; O\u2019Brien A.; Tomatsidou A.; Meyer B.; Vignuzzi M.; Missiakas D.; Botten J.W.; Brooke C.B.; Lee H.; Baker S.C.; Mounce B.C.; Heaton N.S.; Severson W.E.; Palmer K.E.; Dickinson B.C.; Joachimiak A.; Randall G.; Tay S.; Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2. Science  2021,373(6557),931-936","journal-title":"Science"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3390\/ph13100277","volume":"13","author":"Petushkova A.I.","year":"2020","unstructured":"Petushkova A.I.; Zamyatnin A.A.; Papain-like proteases as coronaviral drug targets: Current inhibitors, opportunities, and limitations. pharmaceuticals  2020,13(10),277","journal-title":"pharmaceuticals"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.apsb.2020.08.014","volume":"11","author":"Gao X.","year":"2021","unstructured":"Gao X.; Qin B.; Chen P.; Zhu K.; Hou P.; Wojdyla J.A.; Wang M.; Cui S.; Crystal structure of SARS-CoV-2 papain-like protease. Acta Pharm Sin B  2021,11(1),237-245","journal-title":"Acta Pharm Sin B"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","volume":"41","author":"Huang Y.","year":"2020","unstructured":"Huang Y.; Yang C.; Xu X.; Xu W.; Liu S.; Structural and functional properties of SARS-CoV-2 spike protein: Potential antivirus drug development for COVID-19. Acta Pharmacol Sin  2020,41(9),1141-1149","journal-title":"Acta Pharmacol Sin"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"107986","DOI":"10.1016\/j.biotechadv.2022.107986","volume":"59","author":"Costa C.F.S.","year":"2022","unstructured":"Costa C.F.S.; Barbosa A.J.M.; Dias A.M.G.C.; Roque A.C.A.; Native, engineered and de novo designed ligands targeting the SARS-CoV-2 spike protein. Biotechnol Adv  2022,59,107986","journal-title":"Biotechnol Adv"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","volume":"383","author":"Beigel J.H.","year":"2020","unstructured":"Beigel J.H.; Tomashek K.M.; Dodd L.E.; Mehta A.K.; Zingman B.S.; Kalil A.C.; Hohmann E.; Chu H.Y.; Luetkemeyer A.; Kline S.; Lopez de Castilla D.; Finberg R.W.; Dierberg K.; Tapson V.; Hsieh L.; Patterson T.F.; Paredes R.; Sweeney D.A.; Short W.R.; Touloumi G.; Lye D.C.; Ohmagari N.; Oh M.; Ruiz-Palacios G.M.; Benfield T.; F\u00e4tkenheuer G.; Kortepeter M.G.; Atmar R.L.; Creech C.B.; Lundgren J.; Babiker A.G.; Pett S.; Neaton J.D.; Burgess T.H.; Bonnett T.; Green M.; Makowski M.; Osinusi A.; Nayak S.; Lane H.C.; Remdesivir for the treatment of Covid-19 - Final report. N Engl J Med  2020,383(19),1813-1826","journal-title":"N Engl J Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"n2713","DOI":"10.1136\/bmj.n2713","volume":"375","author":"Mahase E.","year":"2021","unstructured":"Mahase E.; Covid-19: Pfizer\u2019s paxlovid is 89% effective in patients at risk of serious illness, company reports. BMJ  2021,375(2713),n2713","journal-title":"BMJ"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa2116044","volume":"386","author":"Jayk Bernal A.","year":"2022","unstructured":"Jayk Bernal A.; Gomes da Silva M.M.; Musungaie D.B.; Kovalchuk E.; Gonzalez A.; Delos Reyes V.; Mart\u00edn-Quir\u00f3s A.; Caraco Y.; Williams-Diaz A.; Brown M.L.; Du J.; Pedley A.; Assaid C.; Strizki J.; Grobler J.A.; Shamsuddin H.H.; Tipping R.; Wan H.; Paschke A.; Butterton J.R.; Johnson M.G.; De Anda C.; Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients. N Engl J Med  2022,386(6),509-520","journal-title":"N Engl J Med"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"eabo0718","DOI":"10.1126\/scitranslmed.abo0718","volume":"14","author":"Stevens L.J.","year":"2022","unstructured":"Stevens L.J.; Pruijssers A.J.; Lee H.W.; Gordon C.J.; Tchesnokov E.P.; Gribble J.; George A.S.; Hughes T.M.; Lu X.; Li J.; Perry J.K.; Porter D.P.; Cihlar T.; Sheahan T.P.; Baric R.S.; G\u00f6tte M.; Denison M.R.; Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms. Sci Transl Med  2022,14(656),eabo0718","journal-title":"Sci Transl Med"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1038\/s41467-022-29104-y","volume":"13","author":"Gandhi S.","year":"2022","unstructured":"Gandhi S.; Klein J.; Robertson A.J.; Pe\u00f1a-Hern\u00e1ndez M.A.; Lin M.J.; Roychoudhury P.; Lu P.; Fournier J.; Ferguson D.; Mohamed Bakhash S.A.K.; Catherine Muenker M.; Srivathsan A.; Wunder E.A.; Kerantzas N.; Wang W.; Lindenbach B.; Pyle A.; Wilen C.B.; Ogbuagu O.; Greninger A.L.; Iwasaki A.; Schulz W.L.; Ko A.I.; De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: A case report. Nat Commun  2022,13(1),1547","journal-title":"Nat Commun"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"935399","DOI":"10.3389\/fphar.2022.935399","volume":"13","author":"Sakamuru S.","year":"2022","unstructured":"Sakamuru S.; Huang R.; Xia M.; Use of Tox21 screening data to evaluate the covid-19 drug candidates for their potential toxic effects and related pathways. Front Pharmacol  2022,13,935399","journal-title":"Front Pharmacol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1053\/j.ajkd.2022.01.001","volume":"79","author":"Fishbane S.","year":"2022","unstructured":"Fishbane S.; Hirsch J.S.; Nair V.; Special considerations for paxlovid treatment among transplant recipients with SARS-CoV-2 infection. Am J Kidney Dis  2022,79(4),480-482","journal-title":"Am J Kidney Dis"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1080\/07853890.2022.2034936","volume":"54","author":"Wen W.","year":"2022","unstructured":"Wen W.; Chen C.; Tang J.; Wang C.; Zhou M.; Cheng Y.; Zhou X.; Wu Q.; Zhang X.; Feng Z.; Wang M.; Mao Q.; Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19:A meta-analysis. Ann Med  2022,54(1),516-523","journal-title":"Ann Med"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","volume":"23","author":"Jackson C.B.","year":"2022","unstructured":"Jackson C.B.; Farzan M.; Chen B.; Choe H.; Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol  2022,23(1),3-20","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41577-020-00480-0","volume":"21","author":"Dai L.","year":"2021","unstructured":"Dai L.; Gao G.F.; Viral targets for vaccines against COVID-19. Nat Rev Immunol  2021,21(2),73-82","journal-title":"Nat Rev Immunol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.chom.2020.11.004","volume":"28","author":"Zhou T.","year":"2020","unstructured":"Zhou T.; Tsybovsky Y.; Gorman J.; Rapp M.; Cerutti G.; Chuang G.Y.; Katsamba P.S.; Sampson J.M.; Sch\u00f6n A.; Bimela J.; Boyington J.C.; Nazzari A.; Olia A.S.; Shi W.; Sastry M.; Stephens T.; Stuckey J.; Teng I.T.; Wang P.; Wang S.; Zhang B.; Friesner R.A.; Ho D.D.; Mascola J.R.; Shapiro L.; Kwong P.D.; Cryo-EM Structures of SARS-CoV-2 spike without and with ACE2 reveal a ph-dependent switch to mediate endosomal positioning of receptor-binding domains. Cell Host Microbe  2020,28(6),867-879.e5","journal-title":"Cell Host Microbe"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"4828","DOI":"10.1021\/acs.jpcb.2c02365","volume":"126","author":"Li T.","year":"2022","unstructured":"Li T.; Yu L.; Sun J.; Liu J.; He X.; Ionization of D571 Is coupled with sarS-CoV-2 spike Up\/Down equilibrium revealing the pH-Dependent allosteric mechanism of receptor-binding domains. J Phys Chem B  2022,126(26),4828-4839","journal-title":"J Phys Chem B"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jare.2021.11.012","volume":"36","author":"Yi Y.","year":"2022","unstructured":"Yi Y.; Li J.; Lai X.; Zhang M.; Kuang Y.; Bao Y.O.; Yu R.; Hong W.; Muturi E.; Xue H.; Wei H.; Li T.; Zhuang H.; Qiao X.; Xiang K.; Yang H.; Ye M.; Natural triterpenoids from licorice potently inhibit SARS-CoV-2 infection. J Adv Res  2022,36,201-210","journal-title":"J Adv Res"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41586-020-2599-8","volume":"586","author":"Yang J.","year":"2020","unstructured":"Yang J.; Wang W.; Chen Z.; Lu S.; Yang F.; Bi Z.; Bao L.; Mo F.; Li X.; Huang Y.; Hong W.; Yang Y.; Zhao Y.; Ye F.; Lin S.; Deng W.; Chen H.; Lei H.; Zhang Z.; Luo M.; Gao H.; Zheng Y.; Gong Y.; Jiang X.; Xu Y.; Lv Q.; Li D.; Wang M.; Li F.; Wang S.; Wang G.; Yu P.; Qu Y.; Yang L.; Deng H.; Tong A.; Li J.; Wang Z.; Yang J.; Shen G.; Zhao Z.; Li Y.; Luo J.; Liu H.; Yu W.; Yang M.; Xu J.; Wang J.; Li H.; Wang H.; Kuang D.; Lin P.; Hu Z.; Guo W.; Cheng W.; He Y.; Song X.; Chen C.; Xue Z.; Yao S.; Chen L.; Ma X.; Chen S.; Gou M.; Huang W.; Wang Y.; Fan C.; Tian Z.; Shi M.; Wang F.S.; Dai L.; Wu M.; Li G.; Wang G.; Peng Y.; Qian Z.; Huang C.; Lau J.Y.N.; Yang Z.; Wei Y.; Cen X.; Peng X.; Qin C.; Zhang K.; Lu G.; Wei X.; A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Nature  2020,586(7830),572-577","journal-title":"Nature"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41392-020-00318-0","volume":"5","author":"Yu F.","year":"2020","unstructured":"Yu F.; Xiang R.; Deng X.; Wang L.; Yu Z.; Tian S.; Liang R.; Li Y.; Ying T.; Jiang S.; Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2. Signal Transduct Target Ther  2020,5(1),212","journal-title":"Signal Transduct Target Ther"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"n296","DOI":"10.1136\/bmj.n296","volume":"372","author":"Mahase E.","year":"2021","unstructured":"Mahase E.; Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant. BMJ  2021,372(296),n296","journal-title":"BMJ"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"bbab383","DOI":"10.1093\/bib\/bbab383","volume":"23","author":"Wu L.","year":"2022","unstructured":"Wu L.; Peng C.; Yang Y.; Shi Y.; Zhou L.; Xu Z.; Zhu W.; Exploring the immune evasion of SARS-CoV-2 variant harboring E484K by molecular dynamics simulations. Brief Bioinform  2022,23(1),bbab383","journal-title":"Brief Bioinform"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"547","DOI":"10.7326\/M21-4245","volume":"175","author":"Helfand M.","year":"2022","unstructured":"Helfand M.; Fiordalisi C.; Wiedrick J.; Ramsey K.L.; Armstrong C.; Gean E.; Winchell K.; Arkhipova-Jenkins I.; Risk for reinfection after SARS-CoV-2: A living, rapid review for american college of physicians practice points on the role of the antibody response in conferring immunity following SARS-CoV-2 infection. Ann Intern Med  2022,175(4),547-555","journal-title":"Ann Intern Med"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.chom.2020.11.001","volume":"28","author":"Lu M.","year":"2020","unstructured":"Lu M.; Uchil P.D.; Li W.; Zheng D.; Terry D.S.; Gorman J.; Shi W.; Zhang B.; Zhou T.; Ding S.; Gasser R.; Pr\u00e9vost J.; Beaudoin-Bussi\u00e8res G.; Anand S.P.; Laumaea A.; Grover J.R.; Liu L.; Ho D.D.; Mascola J.R.; Finzi A.; Kwong P.D.; Blanchard S.C.; Mothes W.; Real-time conformational dynamics of SARS-CoV-2 spikes on virus particles. Cell Host Microbe  2020,28(6),880-891.e8","journal-title":"Cell Host Microbe"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.str.2021.12.011","volume":"30","author":"Tan Z.W.","year":"2022","unstructured":"Tan Z.W.; Tee W.V.; Samsudin F.; Guarnera E.; Bond P.J.; Berezovsky I.N.; Allosteric perspective on the mutability and druggability of the SARS-CoV-2 Spike protein. Structure  2022,30(4),590-607.e4","journal-title":"Structure"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1126\/science.abd3255","volume":"370","author":"Toelzer C.","year":"2020","unstructured":"Toelzer C.; Gupta K.; Yadav S.K.N.; Borucu U.; Davidson A.D.; Kavanagh Williamson M.; Shoemark D.K.; Garzoni F.; Staufer O.; Milligan R.; Capin J.; Mulholland A.J.; Spatz J.; Fitzgerald D.; Berger I.; Schaffitzel C.; Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein. Science  2020,370(6517),725-730","journal-title":"Science"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"e01485","DOI":"10.1128\/mbio.01485-22","volume":"13","author":"Tong L.","year":"2022","unstructured":"Tong L.; Wang L.; Liao S.; Xiao X.; Qu J.; Wu C.; Zhu Y.; Tai W.; Huang Y.; Wang P.; Li L.; Zhang R.; Xiang Y.; Cheng G.; A retinol derivative inhibits SARS-CoV-2 infection by interrupting spike-mediated cellular entry. MBio  2022,13(4),e01485-e22","journal-title":"MBio"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1021\/acs.jmedchem.1c00320","volume":"65","author":"Wang Q.","year":"2022","unstructured":"Wang Q.; Wang L.; Zhang Y.; Zhang X.; Zhang L.; Shang W.; Bai F.; Probing the allosteric inhibition mechanism of a spike protein using molecular dynamics simulations and active compound identifications. J Med Chem  2022,65(4),2827-2835","journal-title":"J Med Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"6370","DOI":"10.1021\/acs.chemrev.5b00631","volume":"116","author":"Wagner J.R.","year":"2016","unstructured":"Wagner J.R.; Lee C.T.; Durrant J.D.; Malmstrom R.D.; Feher V.A.; Amaro R.E.; Emerging computational methods for the rational discovery of allosteric drugs. Chem Rev  2016,116(11),6370-6390","journal-title":"Chem Rev"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1021\/acs.jproteome.0c00273","volume":"19","author":"Di Paola L.","year":"2020","unstructured":"Di Paola L.; Hadi-Alijanvand H.; Song X.; Hu G.; Giuliani A.; The discovery of a putative allosteric site in the SARS-CoV-2 spike protein Using an integrated structural\/dynamic approach. J Proteome Res  2020,19(11),4576-4586","journal-title":"J Proteome Res"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"5.6.37","DOI":"10.1002\/cpbi.3","volume":"54","author":"Webb B.","year":"2017","unstructured":"Webb B.; Sali A.; Comparative protein structure modeling using MODELLER. Curr Protoc Bioinformatics  2017,54,5.6.37","journal-title":"Curr Protoc Bioinformatics"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1002\/jcc.20290","volume":"26","author":"Case D.A.","year":"2005","unstructured":"Case D.A.; Cheatham T.E.; Darden T.; Gohlke H.; Luo R.; Merz K.M.; Onufriev A.; Simmerling C.; Wang B.; Woods R.J.; The Amber biomolecular simulation programs. J Comput Chem  2005,26(16),1668-1688","journal-title":"J Comput Chem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/1471-2105-10-168","volume":"10","author":"Le Guilloux V.","year":"2009","unstructured":"Le Guilloux V.; Schmidtke P.; Tuffery P.; Fpocket: An open source platform for ligand pocket detection. BMC Bioinformatics  2009,10(1),168","journal-title":"BMC Bioinformatics"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1002\/pro.5560070905","volume":"7","author":"Liang J.","year":"1998","unstructured":"Liang J.; Woodward C.; Edelsbrunner H.; Anatomy of protein pockets and cavities: Measurement of binding site geometry and implications for ligand design. Protein Sci  1998,7(9),1884-1897","journal-title":"Protein Sci"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1021\/acs.jctc.0c01006","volume":"17","author":"Santos-Martins D.","year":"2021","unstructured":"Santos-Martins D.; Solis-Vasquez L.; Tillack A.F.; Sanner M.F.; Koch A.; Forli S.; Accelerating A UTO D OCK 4 with GPUs and Gradient-Based Local Search. J Chem Theory Comput  2021,17(2),1060-1073","journal-title":"J Chem Theory Comput"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"O\u2019Boyle N.M.","year":"2011","unstructured":"O\u2019Boyle N.M.; Banck M.; James C.A.; Morley C.; Vandermeersch T.; Hutchison G.R.; Open Babel: An open chemical toolbox. J Cheminform  2011,3(1),33","journal-title":"J Cheminform"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"Morris G.M.","year":"2009","unstructured":"Morris G.M.; Huey R.; Lindstrom W.; Sanner M.F.; Belew R.K.; Goodsell D.S.; Olson A.J.; AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem  2009,30(16),2785-2791","journal-title":"J Comput Chem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/jcc.20634","volume":"28","author":"Huey R.","year":"2007","unstructured":"Huey R.; Morris G.M.; Olson A.J.; Goodsell D.S.; A semiempirical free energy force field with charge-based desolvation. J Comput Chem  2007,28(6),1145-1152","journal-title":"J Comput Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"W530","DOI":"10.1093\/nar\/gkab294","volume":"49","author":"Adasme M.F.","year":"2021","unstructured":"Adasme M.F.; Linnemann K.L.; Bolz S.N.; Kaiser F.; Salentin S.; Haupt V.J.; Schroeder M.; PLIP 2021: Expanding the scope of the protein\u2013ligand interaction profiler to DNA and RNA. Nucleic Acids Res  2021,49(W1),W530-W534","journal-title":"Nucleic Acids Res"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"Maier J.A.","year":"2015","unstructured":"Maier J.A.; Martinez C.; Kasavajhala K.; Wickstrom L.; Hauser K.E.; Simmerling C.; ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Comput  2015,11(8),3696-3713","journal-title":"J Chem Theory Comput"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"Wang J.","year":"2004","unstructured":"Wang J.; Wolf R.M.; Caldwell J.W.; Kollman P.A.; Case D.A.; Development and testing of a general amber force field. J Comput Chem  2004,25(9),1157-1174","journal-title":"J Comput Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","volume":"23","author":"Ryckaert J.P.","year":"1977","unstructured":"Ryckaert J.P.; Ciccotti G.; Berendsen H.J.C.; Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes. J Comput Phys  1977,23(3),327-341","journal-title":"J Comput Phys"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"6269","DOI":"10.1021\/j100308a038","volume":"91","author":"Berendsen H.J.C.","year":"1987","unstructured":"Berendsen H.J.C.; Grigera J.R.; Straatsma T.P.; The missing term in effective pair potentials. J Phys Chem  1987,91(24),6269-6271","journal-title":"J Phys Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1021\/ct800573m","volume":"5","author":"Sindhikara D.J.","year":"2009","unstructured":"Sindhikara D.J.; Kim S.; Voter A.F.; Roitberg A.E.; Bad seeds sprout perilous dynamics: Stochastic thermostat induced trajectory synchronization in biomolecules. J Chem Theory Comput  2009,5(6),1624-1631","journal-title":"J Chem Theory Comput"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"3668","DOI":"10.1063\/1.470043","volume":"103","author":"Petersen H.G.","year":"1995","unstructured":"Petersen H.G.; Accuracy and efficiency of the particle mesh Ewald method. J Chem Phys  1995,103(9),3668-3679","journal-title":"J Chem Phys"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1080\/00268978800101881","volume":"65","author":"Pastor R.W.","year":"1988","unstructured":"Pastor R.W.; Brooks B.R.; Szabo A.; An analysis of the accuracy of Langevin and molecular dynamics algorithms. Mol Phys  1988,65(6),1409-1419","journal-title":"Mol Phys"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13321-021-00548-6","volume":"13","author":"Bouysset C.","year":"2021","unstructured":"Bouysset C.; Fiorucci S.; ProLIF: A library to encode molecular interactions as fingerprints. J Cheminform  2021,13(1),72","journal-title":"J Cheminform"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1021\/ct400341p","volume":"9","author":"Roe D.R.","year":"2013","unstructured":"Roe D.R.; Cheatham T.E.; PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J Chem Theory Comput  2013,9(7),3084-3095","journal-title":"J Chem Theory Comput"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1021\/ar000033j","volume":"33","author":"Kollman P.A.","year":"2000","unstructured":"Kollman P.A.; Massova I.; Reyes C.; Kuhn B.; Huo S.; Chong L.; Lee M.; Lee T.; Duan Y.; Wang W.; Donini O.; Cieplak P.; Srinivasan J.; Case D.A.; Cheatham T.E.; Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models. Acc Chem Res  2000,33(12),889-897","journal-title":"Acc Chem Res"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A","volume":"20","author":"Weiser J.","year":"1999","unstructured":"Weiser J.; Shenkin P.S.; Still W.C.; Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO). J Comput Chem  1999,20(2),217-230","journal-title":"J Comput Chem"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/s41422-021-00545-2","volume":"31","author":"Tian W.","year":"2021","unstructured":"Tian W.; Li D.; Zhang N.; Bai G.; Yuan K.; Xiao H.; Gao F.; Chen Y.; Wong C.C.L.; Gao G.F.; O-glycosylation pattern of the SARS-CoV-2 spike protein reveals an \u201cO-Follow-N\u201d rule. Cell Res  2021,31(10),1123-1125","journal-title":"Cell Res"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"103329","DOI":"10.1016\/j.isci.2021.103329","volume":"24","author":"Lopez E.","year":"2021","unstructured":"Lopez E.; Barth\u00e9l\u00e9my M.; Baronti C.; Masse S.; Falchi A.; Durbesson F.; Vincentelli R.; de Lamballerie X.; Charrel R.; Coutard B.; Endonuclease-based genotyping of the RBM as a method to track the emergence or evolution of SARS-CoV-2 variants. iScience  2021,24(11),103329","journal-title":"iScience"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"D480","DOI":"10.1093\/nar\/gkaa1100","volume":"49","author":"Bateman A.","year":"2021","unstructured":"Bateman A.; Martin M-J.; Orchard S.; Magrane M.; Agivetova R.; Ahmad S.; Alpi E.; Bowler-Barnett E.H.; Britto R.; Bursteinas B.; Bye-A-Jee H.; Coetzee R.; Cukura A.; Da Silva A.; Denny P.; Dogan T.; Ebenezer T.G.; Fan J.; Castro L.G.; Garmiri P.; Georghiou G.; Gonzales L.; Hatton-Ellis E.; Hussein A.; Ignatchenko A.; Insana G.; Ishtiaq R.; Jokinen P.; Joshi V.; Jyothi D.; Lock A.; Lopez R.; Luciani A.; Luo J.; Lussi Y.; MacDougall A.; Madeira F.; Mahmoudy M.; Menchi M.; Mishra A.; Moulang K.; Nightingale A.; Oliveira C.S.; Pundir S.; Qi G.; Raj S.; Rice D.; Lopez M.R.; Saidi R.; Sampson J.; Sawford T.; Speretta E.; Turner E.; Tyagi N.; Vasudev P.; Volynkin V.; Warner K.; Watkins X.; Zaru R.; Zellner H.; Bridge A.; Poux S.; Redaschi N.; Aimo L.; Argoud-Puy G.; Auchincloss A.; Axelsen K.; Bansal P.; Baratin D.; Blatter M-C.; Bolleman J.; Boutet E.; Breuza L.; Casals-Casas C.; de Castro E.; Echioukh K.C.; Coudert E.; Cuche B.; Doche M.; Dornevil D.; Estreicher A.; Famiglietti M.L.; Feuermann M.; Gasteiger E.; Gehant S.; Gerritsen V.; Gos A.; Gruaz-Gumowski N.; Hinz U.; Hulo C.; Hyka-Nouspikel N.; Jungo F.; Keller G.; Kerhornou A.; Lara V.; Le Mercier P.; Lieberherr D.; Lombardot T.; Martin X.; Masson P.; Morgat A.; Neto T.B.; Paesano S.; Pedruzzi I.; Pilbout S.; Pourcel L.; Pozzato M.; Pruess M.; Rivoire C.; Sigrist C.; Sonesson K.; Stutz A.; Sundaram S.; Tognolli M.; Verbregue L.; Wu C.H.; Arighi C.N.; Arminski L.; Chen C.; Chen Y.; Garavelli J.S.; Huang H.; Laiho K.; McGarvey P.; Natale D.A.; Ross K.; Vinayaka C.R.; Wang Q.; Wang Y.; Yeh L-S.; Zhang J.; Ruch P.; Teodoro D.; UniProt: The universal protein knowledgebase in 2021. Nucleic Acids Res  2021,49(D1),D480-D489","journal-title":"Nucleic Acids Res"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"477133","DOI":"10.1101\/2022.01.20.477133","author":"Tsueng G.","year":"2022, 2022","unstructured":"Tsueng G.; Mullen J.L.; Alkuzweny M.; Cano M.; Rush B.; Haag E.; Curators O.; Latif A.A.; Zhou X.; Qian Z.; Hufbauer E.; Zeller M.; Andersen K.G.; Wu C.; Su A.I.; Gangavarapu K.; Hughes L.D.; Outbreak.info research library: A standardized, searchable platform to discover and explore COVID-19 resources. bioRxiv  2022, 2022,477133","journal-title":"bioRxiv"}],"container-title":["Current Computer-Aided Drug Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573409919666230726142418","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/219120\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573409919666230726142418","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T13:17:15Z","timestamp":1722345435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/219120\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573409919666230726142418","relation":{},"ISSN":["1573-4099"],"issn-type":[{"value":"1573-4099","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-02-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}